145 related articles for article (PubMed ID: 31610872)
1. [French ccAFU guidelines - Update 2018-2020: Adrenal cancer].
Savoie PH; Murez T; Fléchon A; Sèbe P; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R177-R195. PubMed ID: 31610872
[TBL] [Abstract][Full Text] [Related]
2. [French ccAFU guidelines - update 2020-2022: malignancy assessment of an adrenal incidentaloma].
Savoie PH; Murez T; Fléchon A; Rocher L; Ferretti L; Morel-Journel N; Camparo P; Méjean A
Prog Urol; 2020 Nov; 30(12S):S331-S352. PubMed ID: 33349429
[TBL] [Abstract][Full Text] [Related]
3. French AFU Cancer Committee Guidelines Update 2022-2024: Adrenal tumor - Assessment of an adrenal incidetaloma and oncological management.
Savoie PH; Murez T; Neuville P; Van Hove A; Rocher L; Fléchon A; Camparo P; Ferretti L; Branger N; Rouprêt M
Prog Urol; 2022 Nov; 32(15):1040-1065. PubMed ID: 36400477
[TBL] [Abstract][Full Text] [Related]
4. [CCAFU's contribution to the French National Cancer Institute's reference frame: Adrenal malignant tumors].
Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Durand X; Fléchon A; Murez T; Mathonnet M; Triponez F; Mirallié E; Coloby P; Soulié M; ;
Prog Urol; 2013 Nov; 23 Suppl 2():S167-74. PubMed ID: 24485291
[TBL] [Abstract][Full Text] [Related]
5. [RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeur de la surrénale French ccAFU guidelines — Update 2018—2020: Adrenal cancer].
Savoie PH; Murez T; Fléchon A; Sèbe P; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2018 Nov; 28(12S):S175-S193. PubMed ID: 30473001
[TBL] [Abstract][Full Text] [Related]
6. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
7. [French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network].
de la Fouchardière C; Haissaguerre M; Decaussin-Petrucci M; Renaudin K; Deschamps F; Mirallié E; Murez T; Pattou F; Rocher L; Savoie PH; Faron M; Taieb D; Tabarin A; Bertherat J; Gimenez-Roqueplo AP; Amar L; Baudin E; Libé R
Bull Cancer; 2023 Oct; 110(10):1063-1083. PubMed ID: 37573200
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of malignant adrenal tumors.
Kopf D; Goretzki PE; Lehnert H
J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859
[TBL] [Abstract][Full Text] [Related]
9. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
10. Clinical review: Adrenocortical carcinoma: clinical update.
Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2027-37. PubMed ID: 16551738
[TBL] [Abstract][Full Text] [Related]
11. [French ccAFU guidelines - Update 2018-2020: Retroperitoneal sarcoma].
Murez T; Savoie PH; Fléchon A; Durand X; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R167-R176. PubMed ID: 31610871
[TBL] [Abstract][Full Text] [Related]
12. [French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma].
Rouprêt M; Xylinas E; Colin P; Houédé N; Compérat E; Audenet F; Larré S; Masson-Lecomte A; Pignot G; Brunelle S; Roumiguié M; Neuzillet Y; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R34-R47. PubMed ID: 31610873
[TBL] [Abstract][Full Text] [Related]
13. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
14. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
[TBL] [Abstract][Full Text] [Related]
15. [French ccAFU guidelines - Update 2018-2020: Testicular germ cell tumors].
Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R149-R166. PubMed ID: 31610870
[TBL] [Abstract][Full Text] [Related]
16. Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.
Luton JP; Martinez M; Coste J; Bertherat J
Eur J Endocrinol; 2000 Jul; 143(1):111-7. PubMed ID: 10870039
[TBL] [Abstract][Full Text] [Related]
17. [French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].
Bensalah K; Albiges L; Bernhard JC; Bigot P; Bodin T; Boissier R; Correas JM; Gimel P; Hetet JF; Long JA; Nouhaud FX; Ouzaïd I; Rioux-Leclercq N; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R5-R33. PubMed ID: 31610874
[TBL] [Abstract][Full Text] [Related]
18. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1125-1133. PubMed ID: 30117750
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical cancer: pathophysiology and clinical management.
Libè R; Fratticci A; Bertherat J
Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
[TBL] [Abstract][Full Text] [Related]
20. [Our experience regarding a series of adrenal surgical diseases].
Popovici A; Tonea A; Grigoroiu M; Nica A
Chirurgia (Bucur); 2001; 96(4):341-54. PubMed ID: 12731199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
